Cognitive therapy for the prevention of psychosis in people at ultra-high risk: Randomised controlled trial

Morrison, Anthony P., French, Paul, Walford, Lara, Lewis, Shôn W., Kilcommons, Aoiffe, Green, Joanne, Parker, Sophie, Bentall, Richard P.·2004·British Journal of Psychiatry

Cited by (739)

Items 201–300 of 739

  1. Progression from being at-risk to psychosis: next steps
    J. Addington, M. Farris, D. Devoe, Paul D. Metzak · 2020 · npj Schizophrenia
  2. Cognitive Behavioral Therapy for Prodromal Stage of Psychosis—Outcomes for Transition, Functioning, Distress, and Quality of Life: A Systematic Review and Meta-analysis
    Yuchen Zheng, Tingting Xu, Yikang Zhu, Chunbo Li, Jijun Wang, Steven Livingstone, Tianhong Zhang · 2021 · Schizophrenia Bulletin
  3. Kraepelin and psychotic prodromal conditions
    Joachim Klosterkötter, Frauke Schultze‐Lutter, Stephan Ruhrmann · 2008 · European Archives of Psychiatry and Clinical Neuroscience
  4. Auditory hallucinations: a review of assessment tools
    Kirk Ratcliff, John Farhall, Frances Shawyer · 2010 · Clinical Psychology & Psychotherapy
  5. Obsessive compulsive symptoms in individuals at clinical risk for psychosis: Association with depressive symptoms and suicidal ideation
    DeVylder, Jordan E., Oh, Amy J., Ben-David, Shelly, Azimov, Neyra, Harkavy-Friedman, Jill M., Corcoran, Cheryl M. · 2012 · Schizophrenia Research
  6. NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders—medium-term follow-up and clinical course
    Barnaby Nelson, G. Paul Amminger, Hok Pan Yuen, Connie Markulev, Suzie Lavoie, Miriam R. Schäfer, Jessica Hartmann, Nilufar Mossaheb, Monika Schlögelhofer, Stefan Smesny et al. · 2018 · Schizophrenia
  7. Early Intervention for psychosis
    Max Marshall, John Rathbone · 2006 · Cochrane Database of Systematic Reviews
  8. Randomized, Placebo-Controlled Clinical Trial of Omega-3 as Supplemental Treatment in Schizophrenia
    Hamidreza Jamilian, Hassan Solhi, Mehri Jamilian · 2014 · Global Journal of Health Science
  9. Recent approaches to psychological interventions for people at risk of psychosis
    Andreas Bechdolf, Lisa Phillips, Shona M. Francey, Steven Leicester, Anthony P. Morrison, Verena Veith, Joachim Klosterkötter, Patrick D. McGorry · 2006 · European Archives of Psychiatry and Clinical Neuroscience
  10. Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: A comparison of prodromal psychotic symptoms and general functioning
    Marco Armando, Paolo Girardi, Stefano Vicari, Deny Menghini, Maria Cristina Digilio, Maria Pontillo, Riccardo Saba, Luigi Mazzone, Ashleigh Peng Lin, Claudia M. Klier et al. · 2012 · Schizophrenia Research
  11. Psychoeducational multi‐family group treatment with adolescents at high risk for developing psychosis
    Mary P. O’Brien, Jamie L. Zinberg, Carrie E. Bearden, Melita L. Daley, Tara A. Niendam, Alex J. Kopelowicz, Tyrone D. Cannon · 2007 · Early Intervention in Psychiatry
  12. Suicide Risk, Stress Sensitivity, and Self-Esteem among Young Adults Reporting Auditory Hallucinations
    Jordan DeVylder, Matthew R. Hilimire · 2015 · Health & Social Work
  13. Prediction of conversion to psychosis: review and future directions
    Dylan G. Gee, Tyrone D. Cannon · 2011 · Brazilian Journal of Psychiatry
  14. Portland Identification and Early Referral: A Community-Based System for Identifying and Treating Youths at High Risk of Psychosis
    William R. McFarlane, William L. Cook, Donna Downing, Mary Verdi, Kristen A. Woodberry, Anita Ruff · 2010 · Psychiatric Services
  15. Insight in individuals with an At Risk Mental State☆
    Julia Lappin, Kevin D Morgan, Lucia Valmaggia, Matthew R. Broome, James Woolley, Louise Johns, P. Tabraham, Elvira Bramon, Philip K. McGuire · 2007 · Schizophrenia Research
  16. Application of the Comprehensive Assessment of At‐Risk Mental States (CAARMS) to the Japanese population: reliability and validity of the Japanese version of the CAARMS
    Tetsuo Miyakoshi, Kazunori Matsumoto, Fumiaki Ito, Noriyuki Ohmuro, Hiroo Matsuoka · 2009 · Early Intervention in Psychiatry
  17. CBT in the prevention of psychosis and other severe mental disorders in patients with an at risk mental state: A review and proposed next steps
    Mark van der Gaag, David P. G. van den Berg, Helga K. Ising · 2017 · Schizophrenia Research
  18. Suicide risk in young people at Ultra-High Risk (UHR) of psychosis: Findings from a 2-year longitudinal study
    Lorenzo Pelizza, Michele Poletti, Silvia Azzali, Federica Paterlini, Sara Garlassi, Ilaria Scazza, Luigi Rocco Chiri, Simona Pupo, Maurizio Pompili, Andrea Raballo · 2020 · Schizophrenia Research
  19. Aberrant auditory processing in schizophrenia and in subjects at ultra-high-risk for psychosis
    Shin, K. S., Kim, J. S., Kim, S. N., Koh, Y., Jang, J. H., An, S. K., O'Donnell, B. F., Chung, C. K., Kwon, J. S. · 2012 · Schizophrenia Bulletin
  20. Refinement of diagnosis and disease classification in psychiatry
    Yves Lecrubier · 2008 · European Archives of Psychiatry and Clinical Neuroscience
  21. Childhood abuse and schizotypal personality
    Craig Steel, Sarah L. Marzillier, Pasco R. M. Fearon, Anna Ruddle · 2009 · Social Psychiatry and Psychiatric Epidemiology
  22. Impact of cognitive therapy on internalised stigma in people with at-risk mental states
    Anthony P. Morrison, Max J. Birchwood, Melissa Pyle, Clare Flach, Suzanne Stewart, Rory Edward Byrne, Paul H. Patterson, Peter Brian Jones, David G. Fowler, Andrew Ian Gumley et al. · 2013 · The British Journal of Psychiatry
  23. Youth services: meeting the mental health needs of adolescents
    Nora S. Vyas, Max J. Birchwood, Swaran Preet Singh · 2014 · Irish Journal of Psychological Medicine
  24. Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk Prediction
    Kristin M. Healey, David L. Penn, Diana O. Perkins, Scott W. Woods, Richard S.E. Keefe, Jean Addington · 2017 · Schizophrenia Bulletin
  25. Real-world effectiveness of antipsychotic treatment in psychosis prevention in a 3-year cohort of 517 individuals at clinical high risk from the SHARP (ShangHai At Risk for Psychosis)
    Tianhong Zhang, Lihua Xu, XiaoChen Tang, YanYan Wei, Qiang Hu, YeGang Hu, HuiRu Cui, Yingying Tang, Li Hui, Chunbo Li et al. · 2020 · Australian & New Zealand Journal of Psychiatry
  26. Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort
    Kristin S. Cadenhead, Jean Addington, Tyrone D. Cannon, Barbara A. Cornblatt, Thomas H. McGlashan, Diana O. Perkins, Larry J. Seidman, Ming T. Tsuang, Elaine F. Walker, Scott W. Woods et al. · 2010 · Early Intervention in Psychiatry
  27. Altered auditory processing in frontal and left temporal cortex in 22q11.2 deletion syndrome: A group at high genetic risk for schizophrenia
    Tonia Anahi Rihs, Miralena I. Tomescu, Juliane Britz, Vincent Rochas, Anna Custo, Maude Schneider, Martin Debbané, Stéphan Eliez, Christoph Martin Michel · 2012 · Psychiatry Research Neuroimaging
  28. Temperament and character in individuals at ultra-high risk for psychosis and with first-episode schizophrenia: Associations with psychopathology, psychosocial functioning, and aspects of psychological health
    Yun Young Song, Jee In Kang, Se Joo Kim, Mi Kyung Lee, Eun Min Lee, Suk Kyoon An · 2013 · Comprehensive Psychiatry
  29. The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial
    Louise Birkedal Glenthøj, Birgitte Fagerlund, Lasse Randers, Carsten Rygaard Hjorthøj, Christina Wenneberg, Kristine Krakauer, Astrid Vosgerau, Christian Nyfeldt Gluud, Alice A. Medalia, David Leland Roberts et al. · 2015 · Trials
  30. The reality of at risk mental state services: a response to recent criticisms
    Alison Ruth Yung, Stephen James Wood, ASHOK K. MALLA, Barnaby Nelson, Patrick D. McGorry, Jai L. Shah · 2019 · Psychological Medicine
  31. Psychiatric Disorders in Clinical Genetics II: Individualizing Recurrence Risks
    J. Austin, Christina G. S. Palmer, B. Rosen-Sheidley, P. M. Veach, E. Gettig, H. Peay · 2008 · Journal of Genetic Counseling
  32. Cognitive-Behavioral Therapy of Schizophrenia
    David Kingdon, D. Turkington, Robert D. Friedberg · 1996 · Journal of Cognitive Psychotherapy
  33. Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?
    Melanie Föcking, Patrick Dicker, Lorna M. Lopez, Mary D Cannon, Miriam R. Schäfer, Patrick D. McGorry, Stefan Smesny, David Cotter, G. Paul Amminger · 2016 · BMC Psychiatry
  34. Risperidone Pretreatment Prevents Elevated Locomotor Activity Following Neonatal Hippocampal Lesions
    Richtand, Neil M, Taylor, Benjamin, Welge, Jeffrey A, Ahlbrand, Rebecca, Ostrander, Michelle M, Burr, Jeffrey, Hayes, Scott, Coolen, Lique M, Pritchard, Laurel M, Logue, Aaron et al. · 2006 · Neuropsychopharmacology
  35. Early intervention in psychosis: obstacles and opportunities
    Swaran Preet Singh, Helen Louise Fisher · 2005 · Advances in Psychiatric Treatment
  36. Development of a group and family‐based cognitive behavioural therapy program for youth at risk for psychosis
    Yulia Landa, Kim T. Mueser, Katarzyna Wyka, Erica Shreck, Rachel Jespersen, Michael A. Jacobs, Kenneth W. Griffin, Mark van der Gaag, Valerie F. Reyna, Aaron Tim Beck et al. · 2015 · Early Intervention in Psychiatry
  37. Psychotherapy for adolescents and young adults at high risk for psychosis: a systematic review
    Nana Okuzawa, Emily R. Kline, Janine Fuertes, Shobhit Negi, Gloria M. Reeves, Seth S. Himelhoch, Jason Eric Schiffman · 2014 · Early Intervention in Psychiatry
  38. Association between locus of control in childhood and psychotic symptoms in early adolescence: Results from a large birth cohort
    Andrew David Thompson, Sarah A. Sullivan, Glyn Lewis, Stanley Zammit, Jon Heron, Jeremy P. Horwood, Kate Thomas, David Gunnell, Chris P. Hollis, Dieter Wolke C et al. · 2011 · Cognitive Neuropsychiatry
  39. Coping styles predict responsiveness to cognitive behaviour therapy in psychosis
    Preethi Premkumar, EMMANUELLE R. PETERS, Dominic G. Fannon, Anantha P. Anilkumar, Elizabeth Kuipers, Veena Kumari · 2011 · Psychiatry Research
  40. Genealogy of instruments for prodrome evaluation of psychosis
    Jean-Gabriel Daneault · 2013 · Frontiers in Psychiatry
  41. Intervention strategies for ultra-high risk for psychosis: Progress in delaying the onset and reducing the impact of first-episode psychosis
    Patrick D. McGorry, Cristina Mei, Jessica Hartmann, Alison Ruth Yung, Barnaby Nelson · 2021 · Schizophrenia Research
  42. Affective reactivity of speech disturbances in schizotypy
    Kyle S. Minor, Alex S. Cohen · 2009 · Journal of Psychiatric Research
  43. Prediction and Prevention in the Clinical High-Risk for Psychosis Paradigm: A Review of the Current Status and Recommendations for Future Directions of Inquiry
    Michelle Worthington, Tyrone D. Cannon · 2021 · Frontiers in Psychiatry
  44. Change in Neuropsychological Functioning over One Year in Youth at Clinical High Risk for Psychosis
    Kristen A. Woodberry, W. McFarlane, A. Giuliano, M. Verdi, W. Cook, S. Faraone, L. Seidman · 2013 · Schizophrenia Research
  45. Adolescent Health 3 - Mental health of young people: a global public-health challenge
    Vikram Patel, Alan J. Flisher, Sarah Elisabeth Hetrick, Patrick D. McGorry · 2007 · The Lancet
  46. Association of Pre-onset Subthreshold Psychotic Symptoms With Longitudinal Outcomes During Treatment of a First Episode of Psychosis
    R. Rosengard, A. Malla, Sally S. Mustafa, S. Iyer, R. Joober, M. Bodnar, M. Lepage, J. Shah · 2019 · JAMA psychiatry
  47. Making the DSM-5
    Joel Paris, James Emerson Phillips · 2013 · Springer eBooks
  48. Prevention and early intervention for mental health problems in 0–25 year olds: Are there evidence-based models of care?
    Catania, Lisa S., Hetrick, Sarah E., Newman, Louise K., Purcell, Rosemary · 2011 · Advances in Mental Health
  49. Cognitive insight in individuals at clinical high risk for psychosis
    David Kimhy, Lauren Jobson‐Ahmed, Shelly Ben‐David, Lisa Ramadhar, Dolores Malaspina, Cheryl Mary Corcoran · 2013 · Early Intervention in Psychiatry
  50. Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study
    Sung‐Wan Kim, Min Jhon, Jae‐Min Kim, Stefan Smesny, Simon Rice, Michael Berk, Claudia M. Klier, Patrick D. McGorry, Miriam R. Schäfer, G. Paul Amminger · 2016 · PLoS ONE
  51. Integrative Circuit Models and Their Implications for the Pathophysiologies and Treatments of the Schizophrenias
    Neal R. Swerdlow · 2010 · Current topics in behavioral neurosciences
  52. Hallucinations in Children and Adolescents: Considerations in the Emergency Setting
    Gail Ann Edelsohn · 2006 · American Journal of Psychiatry
  53. Antipsychotic medication for early episode schizophrenia
    John Robert Bola, Dennis Kao, Haluk Soydan, Clive Elliott Adams · 2011 · Cochrane Database of Systematic Reviews
  54. Wirksamkeit kognitiver Interventionen für Schizophrenie
    Tania M. Lincoln, Christiane Suttner, Yvonne Nestoriuc · 2008 · Psychologische Rundschau
  55. RETRACTED ARTICLE: Staging in Neuropsychiatry: A Heuristic Model for Understanding, Prevention and Treatment
    Patrick D. McGorry · 2010 · Neurotoxicity Research · Retracted
  56. Impaired verbal self-monitoring in individuals at high risk of psychosis
    Louise Johns, Paul Allen, Isabel Valli, Toby Winton‐Brown, Matthew R. Broome, James Woolley, P. Tabraham, Fern Day, Oliver David Howes, Til Wykes et al. · 2009 · Psychological Medicine
  57. Effects of risperidone and paliperidone pre-treatment on locomotor response following prenatal immune activation
    Neil M. Richtand, Rebecca A. Ahlbrand, Paul S. Horn, Kevin E. Stanford, Stefanie L. Bronson, Robert K. McNamara · 2011 · Journal of Psychiatric Research
  58. Biofeedback to treat anxiety in young people at clinical high risk for developing psychosis
    McAusland, Laina, Addington, Jean · 2018 · Early Intervention in Psychiatry
  59. Preventing psychosis in people at clinical high risk: an updated meta-analysis by the World Psychiatric Association Preventive Psychiatry section
    Amedeo Minichino, Cathy Davies, Olga Karpenko, George N. Christodoulou, Rodrigo Ramalho, Sunil Nandha, Stefano Damiani, Umberto Provenzani, Cecilia Maria Esposito, Martina Maria Mensi et al. · 2025 · Molecular Psychiatry
  60. An evidence map of interventions across premorbid, ultra-high risk and first episode phases of psychosis.
    Ping Liu, A. Parker, S. Hetrick, P. Callahan, Stefanie de Silva, R. Purcell · 2010 · Schizophrenia Research
  61. Cost implications of specific and non‐specific treatment for young persons at ultra high risk of developing a first episode of psychosis
    Lisa Phillips, Sue Cotton, Cathrine Mihalopoulos, Sophy T. F. Shih, Alison Ruth Yung, Rob Carter, Patrick D. McGorry · 2009 · Early Intervention in Psychiatry
  62. Cognitive–behaviour therapy for schizophrenia: a review
    Shanaya Rathod, Douglas Turkington · 2005 · Current Opinion in Psychiatry
  63. High stress, low resilience in people at clinical high risk for psychosis: Should we consider a strengths-based approach?
    Lauren Drvaric, Cory J. Gerritsen, Tayyab Rashid, Robert Michael Bagby, Romina Mizrahi · 2015 · Canadian Psychology/Psychologie canadienne
  64. Glutamate and Psychosis Risk
    Egerton, Alice, Fusar-Poli, Paolo, M. Stone, James · 2012 · Current Pharmaceutical Design
  65. Effects of cognitive therapy on the longitudinal development of psychotic experiences in people at high risk of developing psychosis
    Paul French, Nick M. Shryane, Richard P. Bentall, Shôn W. Lewis, Anthony P. Morrison · 2007 · The British Journal of Psychiatry
  66. Integrated Treatment to Achieve Functional Recovery for First-Episode Psychosis
    Marcelo Valencia, Francisco Juárez, Hector Ortega · 2012 · Schizophrenia Research and Treatment
  67. Associations between cognitive biases and domains of schizotypy in a non-clinical sample
    Stephanie A. Sacks, Amy Weisman de Mamani, Cristina P. Garcia · 2012 · Psychiatry Research
  68. A review of potential cognitive and environmental risk markers in children of bipolar parents
    Steven Huntley Jones, Richard P. Bentall · 2008 · Clinical Psychology Review
  69. Depression in schizophrenia and early psychosis: implications for assessment and treatment
    Rachel Upthegrove · 2009 · Advances in Psychiatric Treatment
  70. Mobile intervention for individuals with psychosis, dual disorders, and their common comorbidities: A literature review
    Pennou, Antoine, Lecomte, Tania, Potvin, Stéphane, Khazaal, Yasser · 2019 · Frontiers in Psychiatry
  71. Primary prevention of psychosis through interventions in the symptomatic prodromal phase, a pragmatic Norwegian Ultra High Risk study
    Inge Joa, Jens Gisselgård, Kolbjørn Brønnick, Thomas H. McGlashan, Jan Olav Johannessen · 2015 · BMC Psychiatry
  72. Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: When do they begin to be effective?
    Nilufar Mossaheb, Miriam R. Schäfer, Monika Schlögelhofer, Claudia M. Klier, Sue Cotton, Patrick D. McGorry, G. Paul Amminger · 2013 · Schizophrenia Research
  73. A randomized trial of family focused treatment for adolescents and young adults at risk for psychosis: study rationale, design and methods
    Danielle A. Schlosser, David J. Miklowitz, Mary P. O’Brien, Sandra D. De Silva, Jamie L. Zinberg, Tyrone D. Cannon · 2011 · Early Intervention in Psychiatry
  74. Short-term functional outcome and premorbid adjustment in clinical high-risk patients. Results of the EPOS project
    Raimo K. R. Salokangas, Markus Heinimaa, Tiina From, Eliisa Löyttyniemi, Tuula Ilonen, Sinikka H. Luutonen, Jarmo A. Hietala, Tanja Svirskis, H. Graf von Reventlow, Georg Juckel et al. · 2013 · European Psychiatry
  75. Cognitive behaviour therapy for first episode psychosis: Good for nothing or fit for purpose?
    Anthony P. Morrison · 2009 · Psychosis
  76. Indicated Prevention of Schizophrenia
    Joachim Klosterkötter · 2008 · Deutsches Ärzteblatt international
  77. Multidisciplinary Treatment for Individuals at Clinical High Risk of Developing Psychosis
    Jean Addington, Daniel J. A. Devoe, Olga Santesteban‐Echarri · 2019 · Current Treatment Options in Psychiatry
  78. Attrition rates in trials for adolescents and young adults at clinical high‐risk for psychosis: A systematic review and meta‐analysis
    Megan S. Farris, Daniel J. A. Devoe, Jean Addington · 2019 · Early Intervention in Psychiatry
  79. Evaluation and Treatment of Children and Adolescents With Psychotic Symptoms
    Sibel Algon, James J. Yi, Monica E. Calkins, Christian G. Kohler, Karin E. Borgmann‐Winter · 2012 · Current Psychiatry Reports
  80. Early detection of schizophrenia
    Richard Drake, Shôn W. Lewis · 2005 · Current Opinion in Psychiatry
  81. Identification of young people in the early stages of psychosis: Validation of a checklist for use in primary care
    Paul French, Jane Owens, Sophie Parker, Graham Dunn · 2012 · Psychiatry Research
  82. Valuing prodromal psychosis: What do we get and what is the price?
    Richard Drake, Shôn W. Lewis · 2010 · Schizophrenia Research
  83. Early intervention in schizophrenia: Current and future perspectives
    Matcheri S. Keshavan, Ali Amirsadri · 2007 · Current Psychiatry Reports
  84. Memory-Prediction Errors and Their Consequences in Schizophrenia
    Michael Kraus, Richard S.E. Keefe, Ranga K. Rama Krishnan · 2009 · Neuropsychology Review
  85. Neuroprotection: A New Strategy in the Treatment of Schizophrenia
    Jeffrey Alan Lieberman, P.F. Buckley, Diana O. Perkins · 2007 · CNS Spectrums
  86. Stigma toward psychosis and its formulation process: prejudice and discrimination against early stages of schizophrenia
    Yoko Baba, Takahiro Nemoto, Naohisa Tsujino, Taiju Yamaguchi, Naoyuki Katagiri, Masafumi Mizuno · 2016 · Comprehensive Psychiatry
  87. Treatment Implications of the Schizophrenia Prodrome
    Tejal Kaur, Kristin S. Cadenhead · 2010 · Current topics in behavioral neurosciences
  88. Cognitive‐Behavioural Interventions
    Suzanne Jolley, Philippa Anne Garety · 2011 · Wiley eBooks
  89. Use of Palm computer as an adjunct to cognitive–behavioural therapy with an ultra‐high‐risk patient: a case report
    David Kimhy, Cheryl Mary Corcoran · 2008 · Early Intervention in Psychiatry
  90. Is early intervention in psychosis effective?
    Angelo Ricciardi, Victoria McAllister, Paola Dazzan · 2008 · Epidemiologia e Psichiatria Sociale
  91. Practitioner perceptions of attenuated psychosis syndrome
    Elizabeth Jacobs, Emily R. Kline, Jason Eric Schiffman · 2011 · Schizophrenia Research
  92. "Attenuated psychotic symptoms syndrome" as a risk syndrome of psychosis, diagnosis in DSM-V: The debate
    Amresh Shrivastava, Patrick D. McGorry, Ming T. Tsuang, ScottW Woods, Barbara A. Cornblatt, Cheryl Mary Corcoran, William T. Carpenter · 2011 · Indian Journal of Psychiatry
  93. Cannabis and psychometrically-defined schizotypy: Use, problems and treatment considerations
    Alex S. Cohen, Julia D. Buckner, Gina M. Najolia, Diana W. Stewart · 2010 · Journal of Psychiatric Research
  94. Mental Health in Childhood and Adolescence: The Role of Polyunsaturated Fatty Acids
    Paola Bozzatello, Cecilia Blua, Paola Rocca, Silvio Bellino · 2021 · Biomedicines
  95. The Borders of Mental Disorder in Psychiatry and the DSM
    Joseph M. Pierre · 2010 · Journal of Psychiatric Practice
  96. Treating young individuals at clinical high risk for psychosis
    Catherine Marshall, Jean Addington, Irvin Epstein, Lu Liu, Stephanie Deighton, Robert B. Zipursky · 2011 · Early Intervention in Psychiatry
  97. Should a risk syndrome for first episode psychosis be included in the DSM-5?
    Barnaby Nelson, Alison Ruth Yung · 2010 · Current Opinion in Psychiatry
  98. Frontal delta power associated with negative symptoms in ultra-high risk individuals who transitioned to psychosis
    Suzie Lavoie, Miriam R. Schäfer, Thomas J. Whitford, Franz Benninger, Martha Feucht, Claudia M. Klier, Hok Pan Yuen, Christos Pantelis, Patrick D. McGorry, G. Paul Amminger · 2012 · Schizophrenia Research
  99. Psychological interventions for people with psychotic experiences: A systematic review and meta-analysis of controlled and uncontrolled effectiveness and economic studies
    Emma Soneson, Debra A Russo, Jan Štochl, Margaret Heslin, Julieta Galante, Clare Knight, Nick Grey, Joanne Hodgekins, Paul French, David G. Fowler et al. · 2020 · Australian & New Zealand Journal of Psychiatry
  100. Effects of Aripiprazole on Insight and Subjective Experience in Individuals With an At-Risk Mental State
    Hiroyuki Kobayashi, Keiko Morita, Kiyoaki Takeshi, Hiroki Koshikawa, Ryoko Yamazawa, Haruo Kashima, Masafumi Mizuno · 2009 · Journal of Clinical Psychopharmacology